Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan;131(1):15-25.
doi: 10.1111/1471-0528.17573. Epub 2023 Jun 20.

Trends and patterns of antiseizure medication prescribing during pregnancy between 1995 and 2018 in the United Kingdom: A cohort study

Paul Madley-Dowd  1   2   3 , Jessica Rast  4   5 , Viktor H Ahlqvist  2   6 , Caichen Zhong  4 , Florence Z Martin  1   2 , Neil M Davies  2   7   8   9 , Kristen Lyall  5 , Craig Newschaffer  10 , Torbjörn Tomson  11 , Cecilia Magnusson  6   12 , Dheeraj Rai  1   2   13   14 , Brian K Lee  4   5   6 , Harriet Forbes  1   14
Affiliations

Trends and patterns of antiseizure medication prescribing during pregnancy between 1995 and 2018 in the United Kingdom: A cohort study

Paul Madley-Dowd et al. BJOG. 2024 Jan.

Abstract

Objective: To examine antiseizure medication (ASM) prescription during pregnancy.

Design: Population-based drug utilisation study.

Setting: UK primary and secondary care data, 1995-2018, from the Clinical Practice Research Datalink GOLD version.

Population or sample: 752 112 completed pregnancies among women registered for a minimum of 12 months with an 'up to standard' general practice prior to the estimated start of pregnancy and for the duration of their pregnancy.

Methods: We described ASM prescription across the study period, overall and by ASM indication, examined patterns of prescription during pregnancy including continuous prescription and discontinuation, and used logistic regression to investigate factors associated with those ASM prescription patterns.

Main outcome measures: Prescription of ASMs during pregnancy and discontinuation of ASMs before and during pregnancy.

Results: ASM prescription during pregnancy increased from 0.6% of pregnancies in 1995 to 1.6% in 2018, driven largely by an increase in women with indications other than epilepsy. Epilepsy was an indication for 62.5% of pregnancies with an ASM prescription and non-epilepsy indications were present for 66.6%. Continuous prescription of ASMs during pregnancy was more common in women with epilepsy (64.3%) than in women with other indications (25.3%). Switching ASMs was infrequent (0.8% of ASM users). Factors associated with discontinuation included age ≥35, higher social deprivation, more frequent contact with the GP and being prescribed antidepressants or antipsychotics.

Conclusions: ASM prescription during pregnancy increased between 1995 and 2018 in the UK. Patterns of prescription around the pregnancy period vary by indication and are associated with several maternal characteristics.

Keywords: antiseizure medication; bipolar disorder; epilepsy; neuropathic pain; pregnancy.

PubMed Disclaimer

Conflict of interest statement

Disclosure of interests: No authors had any interests to disclose.

Figures

Figure 1:
Figure 1:
Annual prevalence of ASMs prescribing during pregnancy between 1995 and 2018, (a) overall and (b) by indication at pregnancy start.
Figure 2:
Figure 2:
Proportion of pregnant women prescribed each ASM anytime in pregnancy during the study period, by indication.
Figure 3:
Figure 3:
Percentage of pregnancies where ASMs were prescribed before and during pregnancy by ASM indication.
Figure 4:
Figure 4:
Proportion of pregnancies with different patterns of prescription among women prescribed ASMs in the pre-pregnancy period or during pregnancy.
See this image and copyright information in PMC

References

    1. Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;164(12):1817–1824; quiz 1923. - PubMed
    1. Tomson T, Battino D, Bromley R, et al. Executive Summary: Management of epilepsy in pregnancy: A report from the International League Against Epilepsy Task Force on Women and Pregnancy. Epilepsia. 2019;60(12):2343–2345. - PubMed
    1. Agency MaHpR. Drugs Safety Update: Latest advice for medicines users. In. Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review. Vol 142021.
    1. Bjørk M-H, Zoega H, Leinonen MK, et al. Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability. JAMA neurology. 2022;79(7):672–681. - PubMed
    1. Hurault-Delarue C, Morris JK, Charlton R, et al. Prescription of antiepileptic medicines including valproate in pregnant women: A study in three European countries. Pharmacoepidemiol Drug Saf. 2019;28(11):1510–1518. - PubMed

Substances